Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden
The European Journal of Health Economics · 2025
DOI: 10.1007/s10198-024-01678-y ↗Kurz gefasst
Fachartikel in der Zeitschrift The European Journal of Health Economics, 2025. Verfasst von Thomas Sejersen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Neurology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Health Care Costs, Patient Acceptance of Health Care, Health Resources. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche.
Abstract (Originalsprache)
Background
Spinal muscular atrophy (SMA) is a rare, progressive, neuromuscular disorder. Recent advances in treatment require an updated assessment of burden to inform reimbursement decisions.
Objectives
To quantify healthcare resource utilisation (HCRU) and cost of care for patients with SMA.
Methods
Cohort study of patients with SMA identified in the Swedish National Patient Registry (2007–2018), matched to a reference cohort grouped into four SMA types (1, 2, 3, unspecified adult onset [UAO]). HCRU included inpatient admissions, outpatient visits, procedures, and dispensed medications. Direct medical costs were estimated by multiplying HCRU by respective unit costs. Average annual HCRU and medical costs were modelled for SMA versus reference cohorts to estimate differences attributable to the disease (i.e., average treatment effect estimand). The trajectory of direct costs over time were assessed using synthetic cohorts.
Results
We identified 290 SMA patients. Annualised HCRU was higher in SMA patients compared with reference cohorts. Highest risk ratios were observed for inpatient overnight stays for type 1 (risk ratio [RR]: 29.2; 95% confidence interval [CI]: 16.0, 53.5) and type 2 (RR: 23.3; 95% CI: 16.4,33.1). Mean annual direct medical costs per patient for each year since first diagnosis were greatest for type 1 (€114,185 and SMA-attributable: €113,380), type 2 (€61,876 and SMA-attributable: €61,237), type 3 (€45,518 and SMA-attributable: €44,556), and UAO (€4046 and SMA-attributable: €2098). Costs were greatest in the 2–3 years after the first diagnosis for all types. Discussion and conclusion The economic burden attributable to SMA is significant. Further research is needed to understand the burden in other European countries and the impact of new treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child Neurology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
- Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
- Center for Neuromusculoskeletal Restorative Medicine, Hong Kong Science Park, Shatin, New Territories, Hong Kong.
- Evidera Ltd, London, UK.
- Pediatric Rehabilitation Center, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Förderung
- F. Hoffmann-La Roche
Zitieren
APA
Sejersen, T., Graham, S., Ekström, A. B., Kroksmark, A. K., Kwiatkowska, M., Ganz, M. L., Justo, N., Gertow, K., & Simpson, A. (2025). Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden. The European Journal of Health Economics. https://doi.org/10.1007/s10198-024-01678-y
Vancouver
Sejersen T, Graham S, Ekström AB, Kroksmark AK, Kwiatkowska M, Ganz ML, et al. Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden. The European Journal of Health Economics. 2025. doi:10.1007/s10198-024-01678-y
BibTeX
@article{Sejersen2025,
author = {Sejersen, Thomas and Graham, Sophie and Ekström, Anne-Berit and Kroksmark, Anna-Karin and Kwiatkowska, Marta and Ganz, Michael L and Justo, Nahila and Gertow, Karl and Simpson, Alex},
title = {Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden},
journal = {The European Journal of Health Economics},
year = {2025},
doi = {10.1007/s10198-024-01678-y}
}
EUVIMED